200,000+ products from a single source!

sales@angenechem.com

Home > Other Building Blocks > 2158-02-3

2158-02-3

2158-02-3 | morpholine-4-carboxamide

CAS No: 2158-02-3 Catalog No: AG00BV51 MDL No:MFCD00085717

Product Description

Catalog Number:
AG00BV51
Chemical Name:
morpholine-4-carboxamide
CAS Number:
2158-02-3
Molecular Formula:
C5H10N2O2
Molecular Weight:
130.1451
MDL Number:
MFCD00085717
IUPAC Name:
morpholine-4-carboxamide
InChI:
InChI=1S/C5H10N2O2/c6-5(8)7-1-3-9-4-2-7/h1-4H2,(H2,6,8)
InChI Key:
ZKWFSTHEYLJLEL-UHFFFAOYSA-N
SMILES:
NC(=O)N1CCOCC1
EC Number:
218-474-4
NSC Number:
10542

Properties

Complexity:
110  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
130.074g/mol
Formal Charge:
0
Heavy Atom Count:
9  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
130.147g/mol
Monoisotopic Mass:
130.074g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
55.6A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-1.2  

Literature

Title Journal
Synthesis, antitumor, antitrypanosomal and antileishmanial activities of benzo[4,5]canthin-6-ones bearing the N'-(Substituted benzylidene)-carbohydrazide and N-Alkylcarboxamide groups at C-2. Chemical & pharmaceutical bulletin 20120101
Asymmetric synthesis of (+)-galbelgin, (-)-kadangustin J, (-)-cyclogalgravin and (-)-pycnanthulignenes A and B, three structurally distinct lignan classes, using a common chiral precursor. The Journal of organic chemistry 20110819
New classes of alanine racemase inhibitors identified by high-throughput screening show antimicrobial activity against Mycobacterium tuberculosis. PloS one 20110101
Modeling of human prokineticin receptors: interactions with novel small-molecule binders and potential off-target drugs. PloS one 20110101
The oxytocin-oxytocin receptor system and its antagonists as tocolytic agents. International journal of endocrinology 20110101
Structural insights into substrate specificity in variants of N-acetylneuraminic Acid lyase produced by directed evolution. Journal of molecular biology 20101119
In vitro metabolism of indomethacin morpholinylamide (BML-190), an inverse agonist for the peripheral cannabinoid receptor (CB(2)) in rat liver microsomes. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20100911
BML-111, a lipoxin receptor agonist, modulates the immune response and reduces the severity of collagen-induced arthritis. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20080401
Lewis base activation of Lewis acids: catalytic, enantioselective vinylogous aldol addition reactions. The Journal of organic chemistry 20070720
Cannabinoids stimulate fibroblastic colony formation by bone marrow cells indirectly via CB2 receptors. Calcified tissue international 20070101
Lewis base activation of Lewis acids. Vinylogous aldol addition reactions of conjugated N,O-silyl ketene acetals to aldehydes. Journal of the American Chemical Society 20060201
Syntheses and neuraminidase inhibitory activity of multisubstituted cyclopentane amide derivatives. Journal of medicinal chemistry 20040408
Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor. British journal of pharmacology 20030601
BML-190 and AM251 act as inverse agonists at the human cannabinoid CB2 receptor: signalling via cAMP and inositol phosphates. FEBS letters 20030211
Design, synthesis, and structure-activity relationships of macrocyclic hydroxamic acids that inhibit tumor necrosis factor alpha release in vitro and in vivo. Journal of medicinal chemistry 20010802
Effects of cannabinoids on LPS-stimulated inflammatory mediator release from macrophages: involvement of eicosanoids. Journal of cellular biochemistry 20010101

© 2019 Angene International Limited. All rights Reserved.